Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumab †

Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy

(2010) F.- C. Bidard et al.   ANNALS OF ONCOLOGY

Circulating endothelial cells and endothelial progenitors as predictive markers of clinical response to bevacizumab-based first-line treatment in advanced colorectal cancer patients

(2010) M. Ronzoni et al.   ANNALS OF ONCOLOGY

The predictive and prognostic value of circulating endothelial cells in advanced colorectal cancer patients receiving first-line chemotherapy and bevacizumab

(2010) L. H. J. Simkens et al.   ANNALS OF ONCOLOGY

Quantification of Circulating Endothelial Cells by Flow Cytometry

(2009) M. H. Strijbos et al.   CLINICAL CANCER RESEARCH

High Levels of Circulating VEGFR2+ Bone Marrow-Derived Progenitor Cells Correlate with Metastatic Disease in Patients with Pediatric Solid Malignancies

(2009) M. Taylor et al.   CLINICAL CANCER RESEARCH

Predictive Potential of Angiogenic Growth Factors and Circulating Endothelial Cells in Breast Cancer Patients Receiving Metronomic Chemotherapy Plus Bevacizumab

(2009) A. Calleri et al.   CLINICAL CANCER RESEARCH

Association of Computed Tomography Morphologic Criteria With Pathologic Response and Survival in Patients Treated With Bevacizumab for Colorectal Liver Metastases

(2009) Yun Shin Chun   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Pooled Safety and Efficacy Analysis Examining the Effect of Performance Status on Outcomes in Nine First-Line Treatment Trials Using Individual Data From Patients With Metastatic Colorectal Cancer

(2009) Daniel J. Sargent et al.   JOURNAL OF CLINICAL ONCOLOGY

Circulating endothelial cells in oncology: pitfalls and promises

(2008) M H Strijbos et al.   BRITISH JOURNAL OF CANCER

Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study

(2008) Leonard B. Saltz et al.   JOURNAL OF CLINICAL ONCOLOGY

Quantification of circulating mature endothelial cells using a whole blood four-color flow cytometric assay

(2008) Nathalie Jacques et al.   JOURNAL OF IMMUNOLOGICAL METHODS

CD146-based immunomagnetic enrichment followed by multiparameter flow cytometry: a new approach to counting circulating endothelial cells

(2008) A. WIDEMANN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Bevacizumab Improves the Overall and Progression-Free Survival of Patients with Metastatic Colorectal Cancer Treated with 5-Fluorouracil-Based Regimens Irrespective of Baseline Risk

(2008) Fairooz Kabbinavar et al.   ONCOLOGY